Table 5 Summary of effect of body mass index in percutaneous nephrolithotripsy
From: Impact of weight on stone-free rate during percutaneous nephrolithotomy
Study | Number | Study design | Clearance (SFR) | OR. time | Hospital stay | Complications | Blood transfusion | Analgesic use | Auxiliaryprocedure |
|---|---|---|---|---|---|---|---|---|---|
Faeber [16] | 530 | Retrospective Normal Morbidity obesity | ‗ | ↑ | ↑ | ↑ | |||
Pearle (2 institutions) [17] | 236 | Retrospective BMI: ≥ 30 Non selectedseries | ‗ | ‗ | ‗ | ‗ | ‗ | ||
Koo (1 surgeon) [18] | 223 | Retrospective BMI: < 25, 25–29, 30–39, ≥ 40 | ‗ | ‗ | ‗ | ‗ | ‗ | ||
El-Assmy (1 institution)[19] | 1211 | Retrospective BMI: < 25, 25–29, 30–39, ≥ 40 | ‗ | ‗ | ‗ | ‗ | ‗ | ||
Bagrodia (1 surgeon) [20] | 183 | Retrospective BMI: < 25, 25–29, 30–39, ≥ 40 | ‗ | ‗ | ‗ | ‗ | ‗ | ||
CROES* Multi-centers [22] | 5803 | Prospective database BMI: < 25, 25–29, 30–39, ≥ 40 | ↑ | ↑ | ‗ | ‗ | ‗ | ↑ | |
Ortiz* (1 institution) [21] | 255 | Prospective BMI: < 25, 25–29, 30–39, ≥ 40 | ‗ | ↑ | ‗ | ‗ | ‗ | ||
Our study* (1 surgeon) (1 institution) | 123 | Prospective BMI: < 25, 25–29, 30–39, ≥ 40 | ‗ | ↑ | ↑ | ‗ | ‗ |